Research ArticleHEALTH AND MEDICINE

Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia

See allHide authors and affiliations

Science Advances  26 Aug 2020:
Vol. 6, no. 35, eaaz9890
DOI: 10.1126/sciadv.aaz9890

Article Information

vol. 6 no. 35

Online ISSN: 
History: 
  • Received for publication October 28, 2019
  • Accepted for publication July 8, 2020
  • .

Author Information

  1. C. A. Gilroy1,2,
  2. M. E. Capozzi3,
  3. A. K. Varanko1,
  4. J. Tong3,4,
  5. D. A. D'Alessio3,4,
  6. J. E. Campbell3,5 and
  7. A. Chilkoti1,*
  1. 1Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
  2. 2Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA 94720, USA.
  3. 3Duke Molecular Physiology Institute, Duke University, Durham, NC 27701, USA.
  4. 4Department of Medicine, Duke University, Durham, NC 27701, USA.
  5. 5Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27701, USA.
  1. *Corresponding author. Email: chilkoti{at}duke.edu

Altmetric

Article usage

Article usage: August 2020 to January 2021

AbstractFullPdf
Aug 20201942432557
Sep 2020861000346
Oct 202037369149
Nov 202028303125
Dec 20201832289
Jan 20211421366

Stay Connected to Science Advances

Navigate This Article